Vaccination and their importance for lung transplant recipients in a COVID-19 world
Open Access
- 10 August 2021
- journal article
- other
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 14 (11) , 1413-1425
Abstract
Lung transplant patients are immunocompromised because of the medication they receive to prevent rejection, and as a consequence are susceptible to (respiratory) infections. Adequate vaccination st...Keywords
This publication has 81 references indexed in Scilit:
- Immunogenicity of Quadrivalent Human Papillomavirus Vaccine in Organ Transplant RecipientsAmerican Journal of Transplantation, 2013
- Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control studyAnnals of the Rheumatic Diseases, 2013
- Cyclosporin A inhibits the replication of diverse coronavirusesJournal of General Virology, 2011
- The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus InhibitorsPLOS Pathogens, 2011
- Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: Immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccinationVaccine, 2011
- Influenza vaccination responses in human systemic lupus erythematosus: Impact of clinical and demographic featuresArthritis & Rheumatism, 2011
- Vaccines: Correlates of Vaccine‐Induced ImmunityClinical Infectious Diseases, 2008
- Antibody Response to Influenza Immunization in Kidney Transplant Recipients Receiving either Azathioprine or Mycophenolate: A Controlled TrialAmerican Journal of Nephrology, 2008
- Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritisRheumatology, 2005
- Cell-mediated immune response to influenza vaccination in lung transplant recipientsThe Journal of Heart and Lung Transplantation, 2004